Study ID | Population | Location/Source | Age | Sample Size | Effect Size | Results | NOS |
---|---|---|---|---|---|---|---|
[50] | Asymptomatic randomly selected | Sweden/SCAPIS | 50–64 | 25,408 | OR:0.96(0.88, 1.04) | No association | Good |
[2] | Asymptomatic above 40 years | South Korea | 55.9 ± 7.7 | 617 | OR:1.202 (0.830, 1.741) | No association | Good |
[51] | patients with chest pain | Turkey | 57.5 ± 8.6 | 187 | N/A | No association | Good |
[28] | Centrally Obese Non-Diabetic Men | Indonesia | 55.20 ± 6.51 | 60men | Correlation Coefficient (r): 0.077 | No association | Good |
[52] | free of clinical ASCVD | USA/MESA | 61 ± 10 | 5196 | N/A | No association | Good |
[29] | aged 40–79 randomly selected men | Japan/SESSA | 69.5 ± 6.9 | 1035 men | OR:1.13(0.97, 1.32) | No association | Good |
[53] | civil servants aged 35–74 years | Brazil/ELSA | 58 | 3753 | OR:1.28(0.96, 1.70) | No association | Good |
[41] | candidates for computed tomography | Iran | 60 ± 10.5 | 200 | OR:11.8 (3.39,41.29) | Positive association | Weak |
[54] | asymptomatic immigrant | USA/MASALA | 55 ± 9 | 906 | OR:1.17 (0.74, 1.85) | No association | Good |
[55] | Stable without known CAD | Brazil | 63.2 ± 9.6 | 130 | OR: 1.25 (0.34, 4.63) | Not Associated | Good |
[56] | chest pain ± positive treadmill test ± presence of multiple coronary risk factors | 54.83 ± 11.63 | 379 | OR:1.090(1.007, 1.180) | No association | Good |  |
[57] | Tsimane villagers, age < 40 | USA | 40–60 | 705 | N/A | No association | Good |
[42] | people without known CAD | China | 59.2 ± 14.92 | 348 | N/A | Positive association | Good |
[58] | individuals who underwent a non-contrast CT scan and echocardiography | South Korea/CAESAR | 51.1 ± 9.3 | 2276 | N/A | No association | Good |
[33] | age 42 to 52 years, an intact uterus, menstruating within the prior three months | USA/SWAN | 51.3 ± 2.8 | 372 women | OR:1.16 (0.88, 1.53) | No association | Good |
[59] | Healthy Individuals | USA/MESA | 70 ± 8 | 6745 | N/A | No association | Good |
[60] | underwent helical computed tomography | China | 67 ± 11 | 125 | N/A | No association | Good |
[25] | men aged ≥ 45 women aged ≥ 55 | South Korea | 66 ± 6 | 456 | OR:2.812 (1.600, 4.942) | Positive association | Intermediate |
[61] | patients who underwent coronary CT | China | 68.38 ± 10.05 | 157 | N/A | No association | Good |
[30] | selected randomly for enrollment men | Japan/ERA-JUMP | 40–49 | 904 men | OR:0.96(0.80, 1.15) | No association | Good |
[62] | randomly sampled from national registries | Denmark/DanRisk | 50–60 | 1126 | OR:1.00 (0.98, 1.03) | No association | Good |
[46] | the absence of atherosclerotic coronary, cerebrovascular, or peripheral artery disease | Brazil | 85 ± 4 | 208 | OR:3.05 (1.25, 7.42) | Association in Special Population | Good |
[63] | Presence of chest pain/ Abnormal Stress test/ Asymptomatic with multiple ASCVD | USA | 57 ± 1.0 | 92 | N/A | No association | Good |
[45] | participated in a comprehensive health examination in 2010 | South Korea | 42.20 ± 6.89 | 12,030 | N/A | Associated when grouped with HDL | Good |
[43] | randomly a selected group of MESA participants | MESA/USA | 66.96 ± 9.2 | 1827 | N/A | Positive association | Good |
[64] | employees and family members of various industrial companies | Korea | 41.36 ± 7.0 | 24,063 | OR:0.932 (0.743, 1.169) | No association | Good |
[31] | Male subjects from Samsung Medical Center | South Korea | 58% above 50 years | 3408men | N/A | No association | Good |
[32] | Male participants from Samsung Medical Center | South Korea | 57% above 50 Years | 3010 men | N/A | No association | Good |
[65] | participants with clinical suspicion of CHD | Japan | 68.0 ± 11.0 | 1363 | N/A | No association | Good |
[66] | low-intermediate risk for CAD | Turkey | 53 ± 10 | 272 | N/A | No association | Good |
[67] | Asymptomatic individuals | South Korea | 30–86 | 531 | N/A | No association | Good |
[68] | Healthy Individuals | Germany | 61.3 ± 8.7 | 455 | N/A | No association | Good |
[49] | consecutive patients aged 80 years or over Asymptomatic | Brazil | 85 ± 5 | 184 | N/A | Association in Special Population | Good |
[48] | Healthy Individuals | USA/MESA | 64.7 ± 8.7 | 3046 | OR:1.12 (0.96, 1.31) | No association | Good |
[47] | type 2 diabetes and without clinical evidence of CVD | USA/PDHS-SIRCA | 35–75 | 2159 | N/A | Association in Special Population | Good |
[69] | Healthy Individuals | USA/MESA | 45–84 | 6783 | RR: 1.05 (0.99,1.12) | No association | Good |
[70] | asymptomatic, ethnically Middle Eastern Egyptians | Egypt | 50.6 ± 5.9 | 177 | OR:1.101(0.846, 1.431) | No association | Good |
[71] | DHS Participants | Japan/USA | 46.3±9.4 | 3373 | OR:1.02 (1.0, 1.04) | No association | Good |
[72] | patients with symptoms of typical or atypical chest pain | Taiwan | 73±1 | 124 | N/A | No association | Good |
[73] | Hispanic white hypertensive subjects | USA | 66±7 | 354 | N/A | No association | Good |
[74] | Asymptomatic subjects with a family history of premature CAD | USA/SIRCA | Men: 30–65 Women: 35–70 | 914 | OR: Men: 0.92(0.83, 1.04) Women: 1.02(0.94, 1.08) | No association | Good |
[44] | Healthy Individuals | USA/FHS | 5–70 | 321 | N/A | Positive association | Good |